Canna~Fangled Abstracts Delayed Systemic Treatment with Cannabinoid Receptor 2 Agonist Mitigates Spinal Cord Injury-Induced Osteoporosis More Than Acute Treatment Directly after Injury Neurotrauma Rep. 2021 Jun 22;2(1):270-284. doi: 10.1089/neur.2020.0059. eCollection 2021. Michelle A Tucci 1, Yilianys Pride 2, Suzanne Strickland 2, Susanna M Salazar…Freedom WaresJune 22, 2021
Canna~Fangled Abstracts Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy. 2015 Dec 9. Zoja C1, Locatelli M, Corna D, Villa S, Rottoli D, Nava V, Verde R, Piscitelli F, Di Marzo V, Fingerle J, Adam…Freedom WaresDecember 9, 2015
Canna~Fangled Abstracts S-777469, a Novel Cannabinoid Type 2 Receptor Agonist, Suppresses Itch-Associated Scratching Behavior in Rodents through Inhibition of Itch Signal Transmission. 2015 Feb 19;95(1-2):95-103. Haruna T1, Soga M, Morioka Y, Hikita I, Imura K, Furue Y, Yamamoto M, Imura C, Ikeda M, Yamauchi A, Deguchi M, Shichijo…Freedom WaresFebruary 19, 2015